595 related articles for article (PubMed ID: 22015921)
1. Perspectives and opportunities for nanomedicine in the management of atherosclerosis.
Lobatto ME; Fuster V; Fayad ZA; Mulder WJ
Nat Rev Drug Discov; 2011 Oct; 10(11):835-52. PubMed ID: 22015921
[TBL] [Abstract][Full Text] [Related]
2. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine-based strategies for treatment of atherosclerosis.
Schiener M; Hossann M; Viola JR; Ortega-Gomez A; Weber C; Lauber K; Lindner LH; Soehnlein O
Trends Mol Med; 2014 May; 20(5):271-81. PubMed ID: 24594264
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine--prospective therapeutic and diagnostic applications.
Emerich DF
Expert Opin Biol Ther; 2005 Jan; 5(1):1-5. PubMed ID: 15709905
[TBL] [Abstract][Full Text] [Related]
6. Targeting and therapeutic peptides in nanomedicine for atherosclerosis.
Chung EJ
Exp Biol Med (Maywood); 2016 May; 241(9):891-8. PubMed ID: 27022138
[TBL] [Abstract][Full Text] [Related]
7. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
8. The emerging applications of magnetic nanovectors in nanomedicine.
Seeney CE
Pharm Pat Anal; 2015; 4(4):285-304. PubMed ID: 26174567
[TBL] [Abstract][Full Text] [Related]
9. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
Psarros C; Lee R; Margaritis M; Antoniades C
Nanomedicine; 2012 Sep; 8 Suppl 1():S59-68. PubMed ID: 22640906
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.
Chen W; Schilperoort M; Cao Y; Shi J; Tabas I; Tao W
Nat Rev Cardiol; 2022 Apr; 19(4):228-249. PubMed ID: 34759324
[TBL] [Abstract][Full Text] [Related]
12. Nanodelivery systems for improved topical antimicrobial therapy.
Basnet P; Škalko-Basnet N
Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine in the Diagnosis and Treatment of Atherosclerosis-A Systematic Review.
Vaidyanathan K; Gopalakrishnan S
Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):119-131. PubMed ID: 28925905
[TBL] [Abstract][Full Text] [Related]
14. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment.
Zhang X; Centurion F; Misra A; Patel S; Gu Z
Adv Drug Deliv Rev; 2023 Mar; 194():114709. PubMed ID: 36690300
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine: a new frontier in cancer therapeutics.
Lee PY; Wong KK
Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
[TBL] [Abstract][Full Text] [Related]
16. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.
Muthu MS; Mei L; Feng SS
Nanomedicine (Lond); 2014 Jul; 9(9):1277-80. PubMed ID: 25204816
[No Abstract] [Full Text] [Related]
17. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
[TBL] [Abstract][Full Text] [Related]
19. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
